MedTrace Logo

Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia

NCT00003291 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2014-08-08

No results posted yet for this study

Summary

RATIONALE: The identification of gene mutations may allow doctors to better determine the prognosis of children with acute lymphoblastic leukemia.

PURPOSE: This clinical trial is studying gene mutations to see if they are related to prognosis of cancer in children with acute lymphoblastic leukemia.

Conditions

Interventions

GENETIC

cytogenetic analysis

GENETIC

mutation analysis

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Ursula R. Kees, PhD · Telethon Institute for Child Health Research

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-03-31
Primary Completion
2006-03-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003291 on ClinicalTrials.gov